The classical NFkappaB pathway is required for phloroglucinol-induced activation of murine lymphocytes.
Phloroglucinol (PG), a polyphenolic compound, has been proposed to show free radical scavenging, anti-tumor, and immunomodulation effects on immune cells. In this study, we investigated PG for its immunological activity and their molecular mechanisms, specifically focusing on the functional activation of nuclear factor-kappaB (NFkappaB), an important transcription factor involved in the activation and differentiation of lymphocytes, and subsequent recruitment of murine lymphocytes. We tested whether PG may contribute to the activation of immune response through the NFkappaB pathway by (3)H-thymidine incorporation assay, Western blot, intracellular cytokine assays and Electrophoretic mobility shift assay (EMSA) in murine lymphocytes. PG markedly enhanced the proliferation of lymphocytes by inducing the degradation and phosphorylation of IkappaB, which leads to the activation of NFkappaB p65. Also, PG induced the activation of mitogen-activated protein kinases (MAPKs) such as ERK1/2, JNK, and p38, upstream molecules of NFkappaB pathway. In addition, PG augmented the secretion of interleukin (IL)-2 in mature T lymphocytes and their production of IL-2. Furthermore, the application of TPCK significantly reduced the activation of lymphocytes by PG via inhibiting the NFkappaB activation. These results suggest that PG induces the activation of lymphocytes by inducing the proliferative activity and secretion of IL-2 through the classical NFkappaB. The effect of PG on lymphocyte activation was assayed for the first time. These results would also elucidate its underlying mechanism.